Ryota Shibaki

730 citations
23 papers · 316 indexed · h-index 10
Topics
Cancer Immunotherapy and Biomarkers (14 papers)Lung Cancer Treatments and Mutations (10 papers)Lung Cancer Research Studies (7 papers)
Partner nations
JapanUnited StatesNorway

In The Last Decade

Ryota Shibaki

21 papers receiving 314 citations

Peers

Ryota Shibaki
Comparison fields: 5 of 40
  • Oncology 243
  • Pulmonary and Respiratory Medicine 188
  • Immunology 47
  • Molecular Biology 32
  • Epidemiology 18
Replace Xiangjuan Ma with:
Xiangjuan Ma China
Weiheng Hu China
Guangming Tian China
Takehiro Tozuka Japan
Yuequan Shi China
Elisabetta Gambale Italy
Anne Laure Voisin France
Joanne Riemer United States
Masayuki Shirasawa Japan
Luisa Piccin Italy
Ryota Shibaki relative to Xiangjuan Ma China Xiangjuan Ma's profile →
Citations per field
00.5×1.5×
Xiangjuan Ma · 1×
Citations per year

Countries citing papers authored by Ryota Shibaki

Since Specialization
Citations

This map shows the geographic impact of Ryota Shibaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Shibaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Shibaki more than expected).

Fields of papers citing papers by Ryota Shibaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Shibaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Shibaki. The network helps show where Ryota Shibaki may publish in the future.

Co-authorship network of co-authors of Ryota Shibaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Shibaki. A scholar is included among the top collaborators of Ryota Shibaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Shibaki. Ryota Shibaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 4
4 0
5 1
6 8
7 3
8 1
9 1
10 13
11 7
12 9
13 4
14 36
15 14
16 22
17 63
18 17
19 60
20 2

About Ryota Shibaki

Ryota Shibaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 23 papers that have together received 316 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Oncology (243 citations), Pulmonary and Respiratory Medicine (188 citations) and Immunology (47 citations). Ryota Shibaki has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Yuichiro Ohe, Shuji Murakami, Noboru Yamamoto, Yasushi Goto, Yuji Matsumoto, Hidehito Horinouchi, Shintaro Kanda, Nobuyuki Yamamoto, Yutaka Fujiwara and Tatsuya Yoshida. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist and Journal of Pain and Symptom Management.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026